[1]
D. Lorusso, M. Marinaccio, E. Mele, I. Sarno, G. Scambia, and F. Raspagliesi, “Retrospective trial on trabectedin (ET-743) monotherapy in very heavily pretreated advanced ovarian cancer:  ”, CBN, vol. 1, no. 1, pp. 14–17, Oct. 2013.